SEC NEWS
Machete Attacks in Congo Threaten Ebola Response, Boosting Vaccine Demand
Attacks on health workers in Congo risk Ebola spread, likely increasing demand for Merck's Ervebo vaccine.
- Ticker
- MRK
Filing analysis
Merck (MRK) and Johnson & Johnson (JNJ) are key Ebola vaccine suppliers; attacks could accelerate procurement. Congo's instability may also pressure EM risk assets.
All MRK markets, filings and insider activity →
Source: Original SEC filing
Loading…